152 related articles for article (PubMed ID: 28676715)
1. Allantopyrone A interferes with multiple components of the TNF receptor 1 complex and blocks RIP1 modifications in the TNF-α-induced signaling pathway.
Quach HT; Tanigaki R; Yokoigawa J; Yamada Y; Niwa M; Hirano S; Shiono Y; Kimura KI; Kataoka T
J Antibiot (Tokyo); 2017 Aug; 70(9):929-936. PubMed ID: 28676715
[TBL] [Abstract][Full Text] [Related]
2. Allantopyrone A, an α-pyrone metabolite from an endophytic fungus, inhibits the tumor necrosis factor α-induced nuclear factor κB signaling pathway.
Yokoigawa J; Morimoto K; Shiono Y; Uesugi S; Kimura K; Kataoka T
J Antibiot (Tokyo); 2015 Feb; 68(2):71-5. PubMed ID: 25118107
[TBL] [Abstract][Full Text] [Related]
3. Desflurane preconditioning inhibits endothelial nuclear factor-kappa-B activation by targeting the proximal end of tumor necrosis factor-alpha signaling.
Li Y; Zhang X; Zhu B; Xue Z
Anesth Analg; 2008 May; 106(5):1473-9, table of contents. PubMed ID: 18420862
[TBL] [Abstract][Full Text] [Related]
4. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
[TBL] [Abstract][Full Text] [Related]
5. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
O'Donnell MA; Legarda-Addison D; Skountzos P; Yeh WC; Ting AT
Curr Biol; 2007 Mar; 17(5):418-24. PubMed ID: 17306544
[TBL] [Abstract][Full Text] [Related]
7. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Borghi A; Verstrepen L; Beyaert R
Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B Down-Regulates TNF Receptor 1 Expression and Inhibits the TNF-α-Dependent Nuclear Factor κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells.
Kusagawa E; Okuda C; Yamaguchi R; Nakano K; Miyake Y; Kataoka T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806134
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.
Oliver Metzig M; Fuchs D; Tagscherer KE; Gröne HJ; Schirmacher P; Roth W
Oncogene; 2016 Jun; 35(26):3399-409. PubMed ID: 26522725
[TBL] [Abstract][Full Text] [Related]
10. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue.
Pandey MK; Sandur SK; Sung B; Sethi G; Kunnumakkara AB; Aggarwal BB
J Biol Chem; 2007 Jun; 282(24):17340-50. PubMed ID: 17439942
[TBL] [Abstract][Full Text] [Related]
11. Death domain complex of the TNFR-1, TRADD, and RIP1 proteins for death-inducing signaling.
Park YH; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2014 Jan; 443(4):1155-61. PubMed ID: 24361886
[TBL] [Abstract][Full Text] [Related]
12. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.
Ahmad R; Raina D; Trivedi V; Ren J; Rajabi H; Kharbanda S; Kufe D
Nat Cell Biol; 2007 Dec; 9(12):1419-27. PubMed ID: 18037881
[TBL] [Abstract][Full Text] [Related]
13. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
14. Verproside inhibits TNF-α-induced MUC5AC expression through suppression of the TNF-α/NF-κB pathway in human airway epithelial cells.
Lee SU; Sung MH; Ryu HW; Lee J; Kim HS; In HJ; Ahn KS; Lee HJ; Lee HK; Shin DH; Lee Y; Hong ST; Oh SR
Cytokine; 2016 Jan; 77():168-75. PubMed ID: 26318254
[TBL] [Abstract][Full Text] [Related]
15. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
16. A network-centric approach to drugging TNF-induced NF-κB signaling.
Pabon NA; Zhang Q; Cruz JA; Schipper DL; Camacho CJ; Lee REC
Nat Commun; 2019 Feb; 10(1):860. PubMed ID: 30808860
[TBL] [Abstract][Full Text] [Related]
17. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-alpha-mediated activation of NF-kappaB and caspase-8.
Ogura H; Tsukumo Y; Sugimoto H; Igarashi M; Nagai K; Kataoka T
Exp Cell Res; 2008 Apr; 314(6):1406-14. PubMed ID: 18289527
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
19. Yangonin blocks tumor necrosis factor-α-induced nuclear factor-κB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit.
Ma J; Liang H; Jin HR; Dat NT; Zhang SY; Jiang YZ; Nan JX; Li D; Wu X; Lee JJ; Jin X
J Pharmacol Sci; 2012; 118(4):447-54. PubMed ID: 22510965
[TBL] [Abstract][Full Text] [Related]
20. A synthetic peptide derived from A1 module in CRD4 of human TNF receptor-1 inhibits binding and proinflammatory effect of human TNF-alpha.
Cao Y; Wang Z; Bu X; Tang S; Mei Z; Liu P
Inflammation; 2009 Jun; 32(3):139-45. PubMed ID: 19274442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
